 | • レポートコード：MRC2-11QY04350 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は精密がん治療のグローバル市場について調査・分析したレポートです。種類別（ホルモン療法、免疫療法、標的療法、モノクローナル抗体療法、遺伝子療法）市場規模、用途別（病院、診断センター、腫瘍クリニック、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別精密がん治療の競争状況、市場シェア ・世界の精密がん治療市場：種類別市場規模 2015年-2020年（ホルモン療法、免疫療法、標的療法、モノクローナル抗体療法、遺伝子療法） ・世界の精密がん治療市場：種類別市場規模予測 2021年-2026年（ホルモン療法、免疫療法、標的療法、モノクローナル抗体療法、遺伝子療法） ・世界の精密がん治療市場：用途別市場規模 2015年-2020年（病院、診断センター、腫瘍クリニック、研究所） ・世界の精密がん治療市場：用途別市場規模予測 2021年-2026年（病院、診断センター、腫瘍クリニック、研究所） ・北米の精密がん治療市場分析：米国、カナダ ・ヨーロッパの精密がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの精密がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の精密がん治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの精密がん治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Bayer HealthCare、GlaxoSmithKline、OncoGenex Pharmaceuticals、Hospira、Boehringer Ingelheim、AstraZeneca、Aveo Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.
Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in the tumor’s genome.
Market Analysis and Insights: Global Precision Cancer Therapies Market
The global Precision Cancer Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Precision Cancer Therapies Scope and Market Size
Precision Cancer Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Precision Cancer Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals
Market segment by Type, the product can be split into
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy
Market segment by Application, split into
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Precision Cancer Therapies Revenue
1.4 Market by Type
1.4.1 Global Precision Cancer Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hormone Therapy
1.4.3 Immunotherapies
1.4.4 Targeted Therapy
1.4.5 Monoclonal Antibody Therapy
1.4.6 Gene Therapy
1.5 Market by Application
1.5.1 Global Precision Cancer Therapies Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Centers
1.5.4 Oncology Clinics
1.5.5 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Therapies Market Perspective (2015-2026)
2.2 Global Precision Cancer Therapies Growth Trends by Regions
2.2.1 Precision Cancer Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Precision Cancer Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Precision Cancer Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Precision Cancer Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Precision Cancer Therapies Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Therapies Players by Market Size
3.1.1 Global Top Precision Cancer Therapies Players by Revenue (2015-2020)
3.1.2 Global Precision Cancer Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Precision Cancer Therapies Market Concentration Ratio
3.2.1 Global Precision Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapies Revenue in 2019
3.3 Precision Cancer Therapies Key Players Head office and Area Served
3.4 Key Players Precision Cancer Therapies Product Solution and Service
3.5 Date of Enter into Precision Cancer Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Precision Cancer Therapies Historic Market Size by Type (2015-2020)
4.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Precision Cancer Therapies Market Size by Application (2015-2020)
5.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Precision Cancer Therapies Market Size (2015-2020)
6.2 Precision Cancer Therapies Key Players in North America (2019-2020)
6.3 North America Precision Cancer Therapies Market Size by Type (2015-2020)
6.4 North America Precision Cancer Therapies Market Size by Application (2015-2020)
7 Europe
7.1 Europe Precision Cancer Therapies Market Size (2015-2020)
7.2 Precision Cancer Therapies Key Players in Europe (2019-2020)
7.3 Europe Precision Cancer Therapies Market Size by Type (2015-2020)
7.4 Europe Precision Cancer Therapies Market Size by Application (2015-2020)
8 China
8.1 China Precision Cancer Therapies Market Size (2015-2020)
8.2 Precision Cancer Therapies Key Players in China (2019-2020)
8.3 China Precision Cancer Therapies Market Size by Type (2015-2020)
8.4 China Precision Cancer Therapies Market Size by Application (2015-2020)
9 Japan
9.1 Japan Precision Cancer Therapies Market Size (2015-2020)
9.2 Precision Cancer Therapies Key Players in Japan (2019-2020)
9.3 Japan Precision Cancer Therapies Market Size by Type (2015-2020)
9.4 Japan Precision Cancer Therapies Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Precision Cancer Therapies Market Size (2015-2020)
10.2 Precision Cancer Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Precision Cancer Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Precision Cancer Therapies Market Size by Application (2015-2020)
11 India
11.1 India Precision Cancer Therapies Market Size (2015-2020)
11.2 Precision Cancer Therapies Key Players in India (2019-2020)
11.3 India Precision Cancer Therapies Market Size by Type (2015-2020)
11.4 India Precision Cancer Therapies Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Precision Cancer Therapies Market Size (2015-2020)
12.2 Precision Cancer Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Precision Cancer Therapies Market Size by Type (2015-2020)
12.4 Central & South America Precision Cancer Therapies Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Precision Cancer Therapies Introduction
13.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Bayer HealthCare
13.2.1 Bayer HealthCare Company Details
13.2.2 Bayer HealthCare Business Overview
13.2.3 Bayer HealthCare Precision Cancer Therapies Introduction
13.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2015-2020)
13.2.5 Bayer HealthCare Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction
13.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 OncoGenex Pharmaceuticals
13.4.1 OncoGenex Pharmaceuticals Company Details
13.4.2 OncoGenex Pharmaceuticals Business Overview
13.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction
13.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2015-2020)
13.4.5 OncoGenex Pharmaceuticals Recent Development
13.5 Hospira
13.5.1 Hospira Company Details
13.5.2 Hospira Business Overview
13.5.3 Hospira Precision Cancer Therapies Introduction
13.5.4 Hospira Revenue in Precision Cancer Therapies Business (2015-2020)
13.5.5 Hospira Recent Development
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Details
13.6.2 Boehringer Ingelheim Business Overview
13.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction
13.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2015-2020)
13.6.5 Boehringer Ingelheim Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Precision Cancer Therapies Introduction
13.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Aveo Pharmaceuticals
13.8.1 Aveo Pharmaceuticals Company Details
13.8.2 Aveo Pharmaceuticals Business Overview
13.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction
13.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2015-2020)
13.8.5 Aveo Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Precision Cancer Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Precision Cancer Therapies Revenue
Table 3. Ranking of Global Top Precision Cancer Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Precision Cancer Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hormone Therapy
Table 6. Key Players of Immunotherapies
Table 7. Key Players of Targeted Therapy
Table 8. Key Players of Monoclonal Antibody Therapy
Table 9. Key Players of Gene Therapy
Table 10. Global Precision Cancer Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Precision Cancer Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Precision Cancer Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Precision Cancer Therapies Market Share by Regions (2015-2020)
Table 14. Global Precision Cancer Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Precision Cancer Therapies Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Precision Cancer Therapies Market Growth Strategy
Table 20. Main Points Interviewed from Key Precision Cancer Therapies Players
Table 21. Global Precision Cancer Therapies Revenue by Players (2015-2020) (Million US$)
Table 22. Global Precision Cancer Therapies Market Share by Players (2015-2020)
Table 23. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Therapies as of 2019)
Table 24. Global Precision Cancer Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Precision Cancer Therapies Product Solution and Service
Table 27. Date of Enter into Precision Cancer Therapies Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Precision Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 30. Global Precision Cancer Therapies Market Size Share by Type (2015-2020)
Table 31. Global Precision Cancer Therapies Revenue Market Share by Type (2021-2026)
Table 32. Global Precision Cancer Therapies Market Size Share by Application (2015-2020)
Table 33. Global Precision Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 34. Global Precision Cancer Therapies Market Size Share by Application (2021-2026)
Table 35. North America Key Players Precision Cancer Therapies Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Precision Cancer Therapies Market Share (2019-2020)
Table 37. North America Precision Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 38. North America Precision Cancer Therapies Market Share by Type (2015-2020)
Table 39. North America Precision Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 40. North America Precision Cancer Therapies Market Share by Application (2015-2020)
Table 41. Europe Key Players Precision Cancer Therapies Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Precision Cancer Therapies Market Share (2019-2020)
Table 43. Europe Precision Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Precision Cancer Therapies Market Share by Type (2015-2020)
Table 45. Europe Precision Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Precision Cancer Therapies Market Share by Application (2015-2020)
Table 47. China Key Players Precision Cancer Therapies Revenue (2019-2020) (Million US$)
Table 48. China Key Players Precision Cancer Therapies Market Share (2019-2020)
Table 49. China Precision Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 50. China Precision Cancer Therapies Market Share by Type (2015-2020)
Table 51. China Precision Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 52. China Precision Cancer Therapies Market Share by Application (2015-2020)
Table 53. Japan Key Players Precision Cancer Therapies Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Precision Cancer Therapies Market Share (2019-2020)
Table 55. Japan Precision Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Precision Cancer Therapies Market Share by Type (2015-2020)
Table 57. Japan Precision Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Precision Cancer Therapies Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Precision Cancer Therapies Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Precision Cancer Therapies Market Share (2019-2020)
Table 61. Southeast Asia Precision Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Precision Cancer Therapies Market Share by Type (2015-2020)
Table 63. Southeast Asia Precision Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Precision Cancer Therapies Market Share by Application (2015-2020)
Table 65. India Key Players Precision Cancer Therapies Revenue (2019-2020) (Million US$)
Table 66. India Key Players Precision Cancer Therapies Market Share (2019-2020)
Table 67. India Precision Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 68. India Precision Cancer Therapies Market Share by Type (2015-2020)
Table 69. India Precision Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 70. India Precision Cancer Therapies Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Precision Cancer Therapies Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Precision Cancer Therapies Market Share (2019-2020)
Table 73. Central & South America Precision Cancer Therapies Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Precision Cancer Therapies Market Share by Type (2015-2020)
Table 75. Central & South America Precision Cancer Therapies Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Precision Cancer Therapies Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in Precision Cancer Therapies Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. Bayer HealthCare Company Details
Table 83. Bayer HealthCare Business Overview
Table 84. Bayer HealthCare Product
Table 85. Bayer HealthCare Revenue in Precision Cancer Therapies Business (2015-2020) (Million US$)
Table 86. Bayer HealthCare Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Product
Table 90. GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2015-2020) (Million US$)
Table 91. GlaxoSmithKline Recent Development
Table 92. OncoGenex Pharmaceuticals Company Details
Table 93. OncoGenex Pharmaceuticals Business Overview
Table 94. OncoGenex Pharmaceuticals Product
Table 95. OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2015-2020) (Million US$)
Table 96. OncoGenex Pharmaceuticals Recent Development
Table 97. Hospira Company Details
Table 98. Hospira Business Overview
Table 99. Hospira Product
Table 100. Hospira Revenue in Precision Cancer Therapies Business (2015-2020) (Million US$)
Table 101. Hospira Recent Development
Table 102. Boehringer Ingelheim Company Details
Table 103. Boehringer Ingelheim Business Overview
Table 104. Boehringer Ingelheim Product
Table 105. Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2015-2020) (Million US$)
Table 106. Boehringer Ingelheim Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Product
Table 110. AstraZeneca Revenue in Precision Cancer Therapies Business (2015-2020) (Million US$)
Table 111. AstraZeneca Recent Development
Table 112. Aveo Pharmaceuticals Business Overview
Table 113. Aveo Pharmaceuticals Product
Table 114. Aveo Pharmaceuticals Company Details
Table 115. Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2015-2020) (Million US$)
Table 116. Aveo Pharmaceuticals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Therapies Market Share by Type: 2020 VS 2026
Figure 2. Hormone Therapy Features
Figure 3. Immunotherapies Features
Figure 4. Targeted Therapy Features
Figure 5. Monoclonal Antibody Therapy Features
Figure 6. Gene Therapy Features
Figure 7. Global Precision Cancer Therapies Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Oncology Clinics Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Precision Cancer Therapies Report Years Considered
Figure 13. Global Precision Cancer Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Precision Cancer Therapies Market Share by Regions: 2020 VS 2026
Figure 15. Global Precision Cancer Therapies Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Precision Cancer Therapies Market Share by Players in 2019
Figure 18. Global Top Precision Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Therapies as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Precision Cancer Therapies Revenue in 2019
Figure 20. North America Precision Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Precision Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Precision Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Precision Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Precision Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Precision Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Precision Cancer Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
がん治療の世界市場（～2026年） Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer,…- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- モノクローナル抗体療法の世界市場（～2026年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
- がん遺伝子治療の世界市場（～2026年） Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…
- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …